HIP1 and the Promotion of Neoplasia
HIP1 and the Promotion of Neoplasia
批准号:
7385314
负责人:
THEODORA S ROSS
金额:
$2.28万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-01-31
关键词:
AntibodiesApoptosisBinding ProteinsCarcinogensCell ProliferationCell Surface ReceptorsCell SurvivalCell surfaceChimeric ProteinsChromosomal translocationChronic Myelomonocytic LeukemiaClathrinComplementDataDevelopmentDominant-Negative MutationEndocytosisEpidermal Growth Factor ReceptorGenerationsGeneticGrowthGrowth FactorGrowth Factor ReceptorsHuntington DiseaseIncidenceInositolKnock-outKnockout MiceLipid BindingMalignant NeoplasmsMediatingMethylnitrosoureaMusMutateMutationNeoplasmsNerve DegenerationNumbersOncogenicPartner in relationshipPatientsPhenotypePredispositionProteinsRadiationReceptor SignalingRegulationRoleStressTertiary Protein StructureTestingTissuesTransgenic MiceWild Type Mousecarcinogenesiscell growthhuman Huntingtin proteinin vivoleukemiametaplastic cell transformationneoplastictraffickingtumortumorigenesistumorigenic
中文摘要
亨廷顿蛋白相互作用蛋白1(Huntingtin Interaction Protein 1,HIP1)是一种可能参与细胞周期蛋白和肌醇结合的脂质结合蛋白。
由于亨廷顿蛋白与亨廷顿蛋白的相互作用,这种蛋白质在亨廷顿病中发生了突变。它是
发现致癌的HIP1/PDGF_R融合蛋白也与白血病有关,该融合蛋白是由一种
慢性粒单核细胞白血病(CMML)患者T(5;7)染色体易位。
我们假设HIP1参与肿瘤的发生还有另外三个原因。第一,HIP1部分
HIP1/PDGFI3R融合蛋白是细胞转化所必需的。其次,HIP1在
多发性肿瘤(初步数据部分)。HIP1显性负性突变体的表达
(初步数据部分)或HIP1基因缺失会导致细胞凋亡。
我们提出的第一个假设是HIP1是致癌的,它在体内的过度表达导致
癌症。作为推论,我们预测,当HIP1不表达时,将减少对
癌症的发展。其次,我们建议检验髋关节LR补充髋关节1功能的假设(S)
在内吞、细胞生长和癌变中起重要作用。最后,我们建议检验这样一个假设,即监管
网状蛋白介导的HIP1和HIPlr的转运导致生长因子受体(GFR)信号的增加。
我们认为这可能是通过增加细胞表面受体的数量来实现的。
对生长因子的敏感性,从而促进细胞存活和/或生长。
英文摘要
Huntingtin Interacting Protein 1 (HIP1) is a clathrin and inositol lipid binding protein that may be involved in
neurodegeneration by virtue of its interaction with huntingtin, the protein mutated in Huntington's disease. It is
also associated with leukemia by discovery of the oncogenic HIP1/PDGF_R fusion protein that resulted from a
t(5;7) chromosomal translocation in a patient with chronic myelomonocytic leukemia (CMML).
We hypothesize that HIP1 is involved in tumorigenesis for three additional reasons. First, the HIP1 portion
of the HIP1/PDGFI3R fusion protein is necessary for cellular transformation. Second, HIP1 is over-expressed in
multiple tumors (preliminary data section). Third, expression of a dominant negative mutant of HIP1
(preliminary data section) or genetic deletion of HIP1 leads to apoptosis.
The first hypothesis we propose to test is that HIP 1 is tumorigenic and its over-expression in vivo leads to
cancer. As a corollary, we predict that when HIP1 is not expressed, there will be a diminished susceptibility to
the development of cancer. Second, we propose to test the hypothesis that HIP lr complements HIP 1 function(s)
in endocytosis, cell growth and carcinogenesis. Finally, we propose to test the hypothesis that regulation of
clathrin mediated trafficking by HIP1 and HIPlr results in an increase in growth factor receptor (GFR) signaling.
We suggest that this maybe accomplished by increasing the number of the cell surface receptors to increase
sensitivity to growth factor and thereby promote cellular survival and/or growth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Roles and Regulation of BRCA1 in Hematopoiesis
-
批准号:9975892
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2017
-
负责人:THEODORA S ROSS
-
依托单位:
The Roles and Regulation of BRCA1 in Hematopoiesis
-
批准号:9306571
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2017
-
负责人:THEODORA S ROSS
-
依托单位:
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
-
批准号:7915876
-
项目类别:
-
资助金额:$28.14万
-
财政年份:2009
-
负责人:THEODORA S ROSS
-
依托单位:
HIP1 and the Promotion of Neoplasia
-
批准号:6767532
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2003
-
负责人:THEODORA S ROSS
-
依托单位:
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
-
批准号:8006377
-
项目类别:
-
资助金额:$25.81万
-
财政年份:2003
-
负责人:THEODORA S ROSS
-
依托单位:
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
-
批准号:7556753
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2003
-
负责人:THEODORA S ROSS
-
依托单位:
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
-
批准号:7756581
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2003
-
负责人:THEODORA S ROSS
-
依托单位:
HIP1 and the Promotion of Neoplasia
-
批准号:7008860
-
项目类别:
-
资助金额:$24.14万
-
财政年份:2003
-
负责人:THEODORA S ROSS
-
依托单位:
HIP1 and the Promotion of Neoplasia
-
批准号:6849330
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2003
-
负责人:THEODORA S ROSS
-
依托单位:
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
-
批准号:8205025
-
项目类别:
-
资助金额:$28.23万
-
财政年份:2003
-
负责人:THEODORA S ROSS
-
依托单位:
HIP1 and the Promotion of Neoplasia
-
批准号:6569861
-
项目类别:
-
资助金额:$24.94万
-
财政年份:2003
-
负责人:THEODORA S ROSS
-
依托单位:
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
-
批准号:7370028
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2003
-
负责人:THEODORA S ROSS
-
依托单位:
MECHANISM OF TRANSFORMATION BY HIP1/PDGFBR
-
批准号:6126616
-
项目类别:
-
资助金额:$27.02万
-
财政年份:2000
-
负责人:THEODORA S ROSS
-
依托单位:
MECHANISM OF TRANSFORMATION BY HIP1/PDGFBR
-
批准号:6497567
-
项目类别:
-
资助金额:$26.87万
-
财政年份:2000
-
负责人:THEODORA S ROSS
-
依托单位:
MECHANISM OF TRANSFORMATION BY HIP1/PDGFBR
-
批准号:6628205
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2000
-
负责人:THEODORA S ROSS
-
依托单位:
MECHANISM OF TRANSFORMATION BY HIP1/PDGFBR
-
批准号:6721109
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2000
-
负责人:THEODORA S ROSS
-
依托单位:
MECHANISM OF TRANSFORMATION BY HIP1/PDGFBR
-
批准号:6350390
-
项目类别:
-
资助金额:$26.92万
-
财政年份:2000
-
负责人:THEODORA S ROSS
-
依托单位:
NOVEL FUSION PROTEIN IN CMML
-
批准号:6215912
-
项目类别:
-
资助金额:$8.81万
-
财政年份:1998
-
负责人:THEODORA S ROSS
-
依托单位:
NOVEL FUSION PROTEIN IN CMML
-
批准号:2443364
-
项目类别:
-
资助金额:$7.73万
-
财政年份:1998
-
负责人:THEODORA S ROSS
-
依托单位:
NOVEL FUSION PROTEIN IN CMML
-
批准号:2871983
-
项目类别:
-
资助金额:$3.93万
-
财政年份:1998
-
负责人:THEODORA S ROSS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: